Schizophrenia spectrum disorder

1 paper

Latest

2 in 12 months

Cureus11 Sep

Neuropsychiatric Effects of Glucagon-Like Peptide-1 Receptor Agonists in Schizophrenia-Spectrum Disorders: A Systematic Review

Systematic review of randomised trialsGLP-1 receptor agonists

ADA Scientific Sessions 2026 Abstract6 Jun

Glucagon-Like Peptide 1 Receptor Agonists for Antipsychotic-Associated Metabolic Dysfunctions In Patients with Schizophrenia: A Systematic Review and Meta-analysis of Randomized Controlled Trials

ReviewInterventions